TD Asset Management
TNDM icon

TD Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

TD Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-27,200
Closed -$2.4M – 1569
2021
Q1 		$2.4M Sell
27,200
-8,200
-23% -$762K ﹤0.01% 1063
2020
Q4 		$3.39M Buy
35,400
+3,200
+10% +$330K ﹤0.01% 889
2020
Q3 		$3.65M Buy
32,200
+8,200
+34% +$862K 0.01% 788
2020
Q2 		$2.37M Buy
24,000
+13,500
+129% +$1.08M ﹤0.01% 841
2020
Q1 		$676K Sell
10,500
-1,600
-13% -$112K ﹤0.01% 1102
2019
Q4 		$721K Hold
12,100
– – ﹤0.01% 1174
2019
Q3 		$714K Buy
12,100
+1,200
+11% +$76.6K ﹤0.01% 1119
2019
Q2 		$703K Buy
10,900
+200
+2% +$12.9K ﹤0.01% 1120
2019
Q1 		$679K Sell
10,700
-200
-2% -$10.5K ﹤0.01% 1121
2018
Q4 		$414K Buy
10,900
+100
+0.9% +$3.53K ﹤0.01% 1257
2018
Q3 		$463K Buy
+10,800
New +$377K ﹤0.01% 1305

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

TD Asset Management's TNDM Position: Q2 2021 in Review

TD Asset Management sold out of Tandem Diabetes Care (TNDM) in Q2 2021, closing a stake of 27,200 shares — an estimated $2.4M sold.

TD Asset Management first reported a position in TNDM in Q3 2018 and held it in 11 quarters. The position peaked at $3.65M in Q3 2020. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2021.

  • TD Asset Management reported no remaining Tandem Diabetes Care position as of Q2 2021 after selling out during the quarter.
  • TD Asset Management sold 27,200 Tandem Diabetes Care shares in Q2 2021, an estimated $2.4M.
  • TD Asset Management first reported a position in Tandem Diabetes Care in Q3 2018 and held it in 11 quarters.
  • TD Asset Management's Tandem Diabetes Care position peaked at $3.65M in Q3 2020.
  • 303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2021.

Based on TD Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.